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 ABSTRACT 
BACKGROUND AND OBJECTIVE : 
 The prevalence of vitamin B12 deficiency varies from 5.8 % to 30% among 
patients undergoing long-term treatment with metformin. 
DESIGN : 
Cross sectional study. 
METHODS : 
Patients with Type 2 diabetes were selected based on inclusion and exclusion 
criteria. Basic biochemical investigation with peripheral smear done. Serum 
B12 assay were done. Vitamin B12 deficiency is defined as values <180pg/ml. 
Association between vitamin B12 deficiency with duration of metformin 
therapy, duration of diabetes, with age, sex were done. 
RESULTS 
 The mean vitamin B12 level is low as the duration of metformin treatment 
increases. The sex, age relation with development of vitamin B12 deficiency 
was not significant. Mean MCV is higher in the Vitamin B12 deficient group. 
Macrocytosis is mainly noted in the vitamin B12 deficient group. 
CONCLUSION : 
 
Vitamin B12 deficiency occurs in type 2 diabetes mellitus patients treated with 
long-term metformin. The duration of metformin therapy significantly affects 
the development of vitamin B12 deficiency. Macrocytosis occurs in vitamin 
B12 deficient diabetic patients treated with metformin. 
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